Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia

Clinical trial NCT03441516 · UNKNOWN

Trial details

NCT number: NCT03441516
Sponsor: Yuhan Corporation
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2018-04-19
Primary completion: 2019-07-04
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.